TCT refers to a test of liquid-based cytology of the cervix, and when the words squamous cell carcinoma, adenocarcinoma, or adenocarcinoma in situ appear on the test form, it indicates a higher likelihood of the presence of cancer.
Commonly used for cervical cancer screening, TCT is a direct look at the cells of the cervix, and there are multiple results on the report card indicating different patterns of cells in the sample. When the words squamous cell carcinoma, adenocarcinoma, or adenocarcinoma in situ are present it indicates a higher likelihood of cancer and a biopsy is needed to confirm the diagnosis. Further testing is also needed when atypical squamous cells are present.
After a woman is screened for cervical cancer, it is recommended that she have the results interpreted by a medical professional in a timely manner. If there are abnormalities, active measures need to be taken to prevent delayed intervention.